View More View Less
  • 1 Medizinisches Versorgungszentrum München
  • | 2 Semmelweis Egyetem, Általános Orvostudományi Kar Neurológiai Klinika Budapest Balassa u. 6. 1083
Open access

Cross Mark

A cerebrovascularis megbetegedéseket gyakran követik pszichiátriai, neuropszichiátriai kórképek, amelyek közül a poststroke-depresszió fordul elő a leggyakrabban. A poststroke-depresszió gyakorisága a stroke-ot követő első év során 30–35%-ra tehető. A szerzők az irodalmi adatok alapján áttekintik az agyi vérkeringészavart követő hangulatzavar prevalenciáját, patogenezisét, prediszponáló tényezőit, terápiás lehetőségeit. Az utóbbi időben egyre több közlemény felveti a prevenció lehetőségét is. A magas prevalencia ellenére az agyi vérkeringészavart követő hangulatzavart gyakran nem ismerik fel, a kezelés elmaradása pedig hátrányosan befolyásolja a betegek rehabilitációját, életminőségét, a kognitív funkciókat, illetve a stroke-ot követő mortalitást. Orv. Hetil., 2014, 155(34), 1335–1343.

  • Lloyd-Jones, D., Adams, R. J., Brown, T. M., et al.: Executive summary: heart disease and stroke statistics – 2010 update. A report from the American Heart Association. Circulation, 2010, 121, 948–954.

  • National Statistical Office: Social health state, 2010. Health look-round, health service. [Központi Statisztikai Hivatal (KSH): Társadalmi helyzetkép, 2010. Egészségi állapot, egészségügy.] KSH, Budapest, 2010. [Hungarian]

  • Hellmann-Regen, J., Piber, D., Hinkelmann, K., et al.: Depressive syndromes in neurological disorders. Eur. Arch. Psychiatry Clin. Neurosci., 2013, 263(Suppl. 2), S123–S136.

  • Pan, A., Sun, Q., Okereke, O. I., et al.: Depression and risk of stroke morbidity and mortality: a meta-analysis and systematic review. JAMA, 2011, 306(11), 1241–1249.

  • Folstein, M. F., Maiberger, R., McHugh, P. R.: Mood disorder as a specific complication of stroke. J. Neurol. Neurosurg. Psychiatry, 1977, 40(10), 1018–1022.

  • Kraepelin, E.: Psychiatrie. Barth, Leipzig, 1910.

  • Goldstein, K.: The organism: A holistic approach to biology derived from pathological data in man. American Books, New York, 1939.

  • Babinski, J.: Contribution to the study of mental disturbance in organic cerebral hemiplegia. (Anosognosia). Rev. Neurol. (Paris), 1914, 27, 845–848.

  • Ironside, R.: Disorders of laughter due to brain lesions. Brain, 1956, 79(4), 589–609.

  • El Husseini, N., Goldstein, L. B., Peterson, E. D., et al.: Depression and antidepressant use after stroke and transient ischemic attack. Stroke, 2012, 43(6), 1609–1616.

  • Cushman, L. A.: Secondary neuropsychiatric complications in stroke: implications for acute care. Arch. Phys. Med. Rehabil., 1988, 69(10), 877–879.

  • Herrmann, N., Black, S. E., Lawrence, J., et al.: The Sunnybrook Stroke Study: a prospective study of depressive symptoms and functional outcome. Stroke, 1998, 29(3), 618–624.

  • Kotila, M., Numminen, H., Waltimo, O., et al.: Depression after stroke. Results of the FINNSTROKE Study. Stroke, 1998, 29(2), 368–372.

  • De Ryck, A., Fransen, E., Brouns, R.,et al.: Psychosocial problems associated with depression at 18  months poststroke. Int. J. Geriatr. Psychiatry, 2014, 29(2), 144–152.

  • Ayerbe, L., Ayis, S., Crichton, S., et al.: The long-term outcomes of depression up to 10 years after stroke; the South London Stroke Register. J. Neurol. Neurosurg. Psychiatry, 2014, 85(5), 514–521.

  • Spalletta, G., Bossù, P., Ciaramella, A., et al.: The etiology of poststroke depression: a review of the literature and a new hypothesis involving inflammatory cytokines. Mol. Psychiatry, 2006, 11(11), 984–991.

  • Bartoli, F., Lillia, N., Lax, A.,et al.: Depression after stroke and risk of mortality: a systematic review and meta-analysis. Stroke Res. Treat., 2013, 2013, 862978.

  • Sibolt, G., Curtze, S., Melkas, S., et al.: Post-stroke depression and depression-executive dysfunction syndrome are associated with recurrence of ischaemic stroke. Cerebrovasc. Dis., 2013, 36(5–6), 336–343.

  • International statistical classification of diseases and related health problems. Revision 10. [BNO-10: A betegségek és az egészséggel kapcsolatos problémák nemzetközi statisztikai osztályozása (10. revízió).] Népjóléti Minisztérium, Budapest, 1995. [Hungarian]

  • Diagnostic and Statistical Manual of Mental Disorders. 4th Edition. American Psychiatric Association, Washington, 1994.

  • Diagnostic and Statistical Manual of Mental Disorders. 5th Edition. American Psychiatric Pub Inc., American Psychiatric Association, Washington, 2013.

  • Hackett, M. L., Anderson, C. S., House, A.,et al.: J. Interventions for treating depression after stroke. Cochrane Database Syst. Rev., 2008, (4), CD003437.

  • Berg, A., Lönnqvist, J., Palomäki, H., et al.: Assessment of depression after stroke: a comparison of different screening instruments. Stroke, 2009, 40(2), 523–529.

  • Robinson, R. G., Spalletta, G.: Poststroke depression: A review. Can. J. Psychiatry, 2010, 55(6), 341–349.

  • Schubert, D. S. P., Taylor, C., Lee, S., et al.: Detection of depression in the stroke patient. Psychosomatics, 1992, 33(3), 290–294.

  • Bereczki, D., Gesztelyi, R., Kellermann, M., et al.: Post stroke depressive disorders in the acute and chronic phases of stroke: a prospective study. Eur. J. Neurol., 1996, 3(Suppl. 5), 51.

  • Kellermann, M., Fekete, I., Gesztelyi, R., et al.: Screening for depressive symptoms in the acute phase of stroke. Gen. Hosp. Psychiatry, 1999, 21(2), 116–121.

  • Gesztelyi, R., Fekete, I., Kellermann, M., et al.: Screening for depressive symptoms among post-stroke outpatients in Eastern Hungary. J. Geriatr. Psychiatry Neurol., 1999, 12(4), 194–199.

  • Hackett, M. L., Yapa, C., Parag, V., et al.: Frequency of depression after stroke: a systematic review of observational studies. Stroke, 2005, 36(6), 1330–1340.

  • Murakami, T., Hama, S., Yamashita, H., et al.: Neuroanatomic pathways associated with poststroke affective and apathetic depression. Am. J. Geriatr. Psychiatry, 2013, 21(9), 840–847.

  • El Husseini, N., Laskowitz, D. T.: The role of neuroendocrine pathways in prognosis after stroke. Expert. Rev. Neurother., 2014, 14(2), 217–232.

  • Whyte, E. M., Mulsant, B. H.: Post stroke depression: epidemiology, pathophysiology, and biological treatment. Biol. Psychiatry, 2002, 52(3), 253–264.

  • Robinson, R. G., Kubos, K. L., Starr, L. B., et al.: Mood disorders in stroke patients. Importance of location of lesion. Brain, 1984, 107(1), 81–93.

  • Tang, W. K., Lu, J. Y., Chen, Y. K., et al.: Association of frontal subcortical circuits infarcts in poststroke depression: a magnetic resonance imaging study of 591 Chinese patients with ischemic stroke. J. Geriatr. Psychiatry Neurol., 2011, 24(1), 44–49.

  • Kouwenhoven, S. E., Gay, C. L., Bakken, L. N., et al.: Depressive symptoms in acute stroke: a cross-sectional study of their association with sociodemographics and clinical factors. Neuropsychol. Rehabil., 2013, 23(5), 658–677.

  • Zhang, W. N., Pan, Y. H., Wang, X. Y., et al.: A prospective study of the incidence and correlated factors of post-stroke depression in China. PLoS One, 2013, 8(11), e78981.

  • Carson, A. J., MacHale, S., Allen, K., et al.: Depression after stroke and lesion location: a systematic review. Lancet, 2000, 356(9224), 122–126.

  • Hackett, M. L., Andersen, C. S.: Predictors of depression after stroke: a systematic review of observational studies. Stroke, 2005, 36(10), 2296–2301.

  • Lewin, A., Jöbges, M., Werheid, K.: The influence of self-efficacy, pre-stroke depression and perceived social support on self-reported depressive symptoms during stroke rehabilitation. Neuropsychol. Rehabil., 2013, 23(4), 546–562.

  • Deutsche Gesellschaft für Allgemeinmedizin und Familienmedizin: DEGAM-Leitlinie Nr. 8: Schlaganfall. Omikron Publishing, Düsseldorf, 2012.

  • Hamilton, M.: A rating scale for depression. J. Neurol. Neurosurg. Psychiatry, 1960, 23, 56–62.

  • Beck, A. T., Ward, C. H., Mendelson, M., et al.: An inventory for measuring depression. Arch. Gen. Psychiatry, 1961, 4(6), 561–571.

  • Montgomery, S. A., Asberg, M.: A new depression scale designed to be sensitive to change. Br. J. Psychiatry, 1979, 134, 382–389.

  • Kang, H. J., Stewart, R., Kim, J. M., et al.: Comparative validity of depression assessment scales for screening poststroke depression. J. Affect. Disord., 2013, 147(1–3), 186–191.

  • Cole, M. G., Elie, L. M., McCusker, J.,et al.: Feasibility and effectiveness of treatments for post-stroke depression in elderly inpatients: systematic review. J. Geriatr. Psychiatry Neurol., 2001, 14(1), 37–41.

  • Currier, M. B., Murray, G. B., Welch, C. C.: Electroconvulsive therapy for post-stroke depressed geriatric patients. J. Neuropsychiatry Clin. Neurosci., 1992, 4(2), 140–144.

  • Murray, G. B., Shea, V., Conn, D. K.: Electroconvulsive therapy for post-stroke depression. J. Clin. Psychiatry, 1986, 47(5), 258–260.

  • Lipsey, J. R., Robinson, R. G., Pearlson, G. D., et al: Nortriptyline treatment of post-stroke depression: a double-blind study. Lancet, 1984, 1(8372), 297–300.

  • Robinson, R. G., Schultz, S. K., Castillo, C., et al.: Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study. Am. J. Psychiatry, 2000, 157(3), 351–359.

  • Andersen, G., Vestergaard, K., Lauritzen, L.: Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke, 1994, 25(6), 1099–1104.

  • Wiart, L., Petit, H., Joseph, P. A., et al.: Fluoxetine in early poststroke depression: a double-blind placebo controlled study. Stroke, 2000, 31(8), 1829–1832.

  • Fruehwald, S., Gatterbauer, E., Rehak, P., et al.: Early fluoxetine treatment of post-stroke depression – a three-month double-blind placebo-controlled study with an open-label long-term follow up. J. Neurol., 2003, 250(3), 347–351.

  • Murray, V., vonArbin, M., Bartfai, A., et al.: Double-blind comparison of sertraline and placebo in stroke patients with minor depression and less severe major depression. J. Clin. Psychiatry, 2005, 66(6), 708–716.

  • Rampello, L., Chiechio, S., Nicoletti, G., et al.: M. Prediction of the response to citalopram and reboxetine in post-stroke depressed patients. Psychopharmacology, 2004, 173(1–2), 73–78.

  • Kneebone, I. I., Dunmore, E.: Psychological management of post-stroke depression. Br. J. Clin. Psychol., 2000, 39(Pt 1), 53–65.

  • Kootker, J. A., Fasotti, L., Rasquin, S. M., et al.: The effectiveness of an augmented cognitive behavioural intervention for post-stroke depression with or without anxiety (PSDA): the Restore 4Stroke-PSDA trial. BMC Neurol., 2012, 12, 51.

  • Lincoln, N. B., Flannaghan, T.: Cognitive behavioral psychotherapy for depression following stroke: a randomized controlled trial. Stroke, 2003, 34, 111–115.

  • Jorge, R. E., Robinson, R. G., Tateno, A., et al.: Repetitive transcranial magnetic stimulation as treatment of poststroke depression: a preliminary study. Biol. Psychiatry, 2004, 55(4), 398–405.

  • Palomäki, H., Kaste, M., Berg, A., et al.: Prevention of poststroke depression: 1 year randomised placebo controlled double blind trial of mianserin with 6 month follow up after therapy. J. Neurol. Neurosurg. Psychiatry, 1999, 66(6), 490–494.

  • Almeida,O. P., Waterreus, A., Hankey, G. J.: Preventing depression after stroke: Results from a randomized placebo-controlled trial. J. Clin. Psychiatry, 2006, 67(7), 1104–1109.

  • Rasmussen, A.,Lunde, M., Poulsen, D. L., et al.: A double-blind, placebo-controlled study of sertraline in the prevention of depression in stroke patients. Psychosomatics, 2003, 44(3), 216–221.

  • Narushima, K., Kosier, J. T., Robinson, R. G.: Preventing poststroke depression: a 12-week double-blind randomized treatment trial and 21-month follow-up. J. Nerv. Ment. Dis., 2002, 190(5), 296–303.

  • Robinson, R. G., Jorge, R. E., Moser, D. J., et al.: Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial. JAMA, 2008, 299(20), 2391–2400.

  • Zhang, L. S., Hu, X. Y., Yao, L. Y., et al.: Prophylactic effects of duloxetine on post-stroke depression symptoms: an open single-blind trial. Eur. Neurol., 2013, 69(6), 336–343.

  • Yi, Z. M., Liu, F., Zhai, S. D.: Fluoxetine for the prophylaxis of poststroke depression in patients with stroke: a meta-analysis. Int. J. Clin. Pract., 2010, 64(9), 1310–1317.

  • Watkins, C. L., Wathan, J. V., Leathley, M. J., et al.: The 12-month effects of early motivational interviewing after acute stroke: a randomized controlled trial. Stroke, 2011, 42(7), 1956–1961.

  • Jorge,R. E., Robinson, R. G., Arndt, S., et al.: Mortality and poststroke depression: a placebo-controlled trial of antidepressants. Am. J Psychiatry, 2003, 160(10), 1823–1829.

  • Mikami, K., Jorge, R. E., Adams, H. P. Jr., et al.: Effect of antidepressants on the course of disability following stroke. Am. J. Geriatr. Psychiatry, 2011, 19(12), 1007–1015.

  • Hackett, M. L., Anderson, C. S., House, A., et al.: Interventions for preventing depression after stroke. Cochrane Database Syst. Rev., 2008, 16(3), CD003689.

  • Chollet, F., Tardy, J., Albucher, J. F., et al.: Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. Lancet Neurol., 2011, 10(2), 123–130.

  • De Ryck, A., Brouns, R., Fransen, E.,et al.: A prospective study on the prevalence and risk factors of poststroke depression. Cerebrovasc. Dis. Extra, 2013, 3(1), 1–13.

  • Yang, S. R., Hua, P., Shang, X. Y., et al.: Predictors of early post ischemic stroke apathy and depression: a cross-sectional study. BMC Psychiatry, 2013, 13(1), 164.

  • Rajashekaran, P., Pai, K., Thunga, R., et al.: Post-stroke depression and lesion location: A hospital based cross-sectional study. Indian J. Psychiatry, 2013, 55(4), 343–348.

  • De Man-van Ginkel, J. M., Hafsteinsdóttir, T. B., Lindeman, E., et al.: In-hospital risk prediction for post-stroke depression: development and validation of the Post-stroke Depression Prediction Scale. Stroke, 2013, 44(9), 2441–2445.

  • Srivastava, A., Taly, A. B., Gupta, A., et al.: Post-stroke depression: prevalence and relationship with disability in chronic stroke survivors. Ann. Indian Acad. Neurol., 2010, 13(2), 123–127.

  • Ayerbe, L., Ayis, S., Wolfe, C. D., et al.: Natural history, predictors and outcomes of depression after stroke: systematic review and meta-analysis. Br. J. Psychiatry, 2013, 202(1), 14–21.

  • White, J. H., Attia, J., Sturm, J., et al.: Predictors of depression and anxiety in community dwelling stroke survivors: a cohort study. Disabil. Rehabil., 2014 Feb 6. [Epub ahead of print]

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 211 209 26
PDF Downloads 299 297 36